Oops, you're using an old version of your browser so some of the features on this page may not be displaying properly.

MINIMAL Requirements: Google Chrome 24+Mozilla Firefox 20+Internet Explorer 11Opera 15–18Apple Safari 7SeaMonkey 2.15-2.23

Expression of musashi-1 protein and its implications in progression and prognosis of gastric cancer

Date

19 Dec 2015

Session

Poster presentation 1

Presenters

Zhangxuan Shou

Citation

Annals of Oncology (2015) 26 (suppl_9): 42-70. 10.1093/annonc/mdv523

Authors

Z. Shou1, Z. Zhao2, X. Jin3

Author affiliations

  • 1 Department Of Pharmaceutical Science, Zhejiang Provincial People's Hospital, 310014 - Hangzhou/CN
  • 2 Department Of Pathology, Zhejiang Provincial People's Hospital, Hangzhou/CN
  • 3 Department Of Pharmaceutical Science, Zhejiang Provincial People's Hospital, Hangzhou/CN
More

Resources

Abstract 428

Aim/Background

This study was designed to evaluate the expression of Musashi-1 protein and its implications in progression and prognosis of gastric cancer.

Methods

The expression of Musashi-1 protein in frozen gastric cancers and corresponding adjacent non-cancerous gastric mucosae was detected by using western blotting. The expression level of Musashi-1 protein in archived gastric cancers and non-cancerous gastric mucosae was assessed by performing an immunohistochemical staining (EnVision method) on the tissue microarray, and compared with the clinicopathological parameters of patients with gastric cancer.

Results

The expression of Musashi-1 protein in frozen gastric cancers was significantly higher than in non-cancerous gastric mucosae (P < 0.05). There was no significant difference found in Musashi-1 protein expression between intestinal type and diffuse type gastric cancer (P > 0.05). Musashi-1 protein expression was found to be upregulated in 35.3% (154/436) of gastric cancers, significantly higher than in non-cancerous gastric mucosae, and was correlated to age, location, size, depth of invasion, TNM stage, Lauren's classification, vessel invasion, lymph node metastasis, and distant metastasis of tumor. As stratified by TNM stage, the mean survival time for patients with low Musashi-1 expression was significantly longer than that for patients with high Musashi-1 expression in each same TNM stage (P < 0.05). In particular, TNM II patients with low Musashi-1 expression have a longer mean survival time than TNM I patients with high Musashi-1 expression ( P = 0.001), and TNM III patients with low Musashi-1 expression have a longer mean survival time than TNM II patients with high Musashi-1 expression ( P = 0.034). Multivariate Cox regression showed that Musashi-1 protein expression was an independent prognosticator for the survival of the patients with gastric cancer.

Conclusions

Musashi-1 protein plays a critical role in the progression of gastric cancer. Detection of Musashi-1 protein expression alone or in combination with TNM staging is helpful to predict the prognosis of patients with gastric cancer, thereby contributing to personalized chemotherapy regimen.

Disclosure

All authors have declared no conflicts of interest.

Resources from the same session

This site uses cookies. Some of these cookies are essential, while others help us improve your experience by providing insights into how the site is being used.

For more detailed information on the cookies we use, please check our Privacy Policy.

Customise settings